This article is more than 5 years old. Information may no longer be current.
Age, diabetes can adversely affect cervical laminoplasty outcomes
Click Here to Manage Email Alerts
Several risk factors, including age, diabetes and long-term cervical spondylotic myelopathy symptoms, were found to increase the odds of a patient having poor health outcomes following cervical laminoplasty, according to recently published data.
The study included 105 patients with diabetes and cervical spondylotic myelopathy undergoing double-door laminoplasty. Patients’ average duration of symptoms was 17.8 months, and mean follow-up was 25.7 months.
Prior to surgery, all of the patients had their glycated hemoglobin (HbA1c) levels recorded, as determined by the National Glycohemoglobin Standardization Program.
Following the procedure, the researchers divided the patients into one of two groups based on whether they had “good” outcomes or “poor” outcomes. A good outcome was classified as a patient with a recovery rate of 50% or greater, whereas a poor outcome was defined as a recovery rate of less than 50%.
The researchers observed no significant differences in the patients’ demographic data between the two groups, with the exception of age, duration of cervical spondylotic myelopathy symptoms, HbA1c levels and duration of diabetes symptoms.
Patient age of 65 years or older and cervical spondylotic myelopathy duration of 12 months or longer were found to be associated with an increased risk for poor surgical outcomes, according to the researchers. Additionally, HbA1c levels of 6.5% or higher and a diabetes duration of 10 years or longer were also significantly associated with poor treatment outcomes. – by Robert Linnehan
Disclosure: Please see the study for a full list of relevant financial disclosures.
Click Here to Manage Email Alerts